Possible explanations include the specific cellular context, the co-expression of other pro-apoptotic or anti-apoptotic proteins, or the interaction of Bcl-2 with specific signaling pathways unique to certain lung cancer subtypes. The gene discussed is BCL2; the disease is lung carcinoma.